Amgen, J&J recall anemia treatments

Amgen and Johnson & Johnson are recalling their Epogen and Procrit anemia treatments because of the potential for barely visible glass flakes in vials containing the injectable medicines. Report

Suggested Articles

Bayer has withdrawn part of a proposed Roundup settlement after a judge questioned how it's handling potential future claims.

Consensus pegs cabotegravir peak sales at £750 million ($945 million), indicating it can grab about one-third of the current PrEP market.

The CEOs for COVID-19 vaccine partners Pfizer and BioNTech are sounding confident in their program as they gear up for phase 3.